Full text is available at the source.
Abstract
Approximately 112,000 deaths from neuromycoses occur annually, with 19% linked to AIDS.
- Neuromycoses are fungal infections that impact the central nervous system.
- Conventional antifungal treatments face challenges like limited penetration of the blood-brain barrier and increasing resistance.
- Lipid nanoparticles may enhance the effectiveness of antifungal treatments while also modulating immune responses.
- Current knowledge on lipid nanoparticles includes their design, drug delivery methods, and interactions within the body.
- Research outlines a roadmap for using lipid nanoparticles in next-generation treatments for neuromycoses.
Simplified